Natco Pharma announces second interim dividend, demerges agro-chemicals unit

Natco Pharma Limited announced a second interim dividend of Rs.1.50 (75%) per equity share of Rs.2/- each for the financial year 2025-26. The record date for eligible shareholders is fixed for Thursday, November 20, 2025, with dividend payments commencing November 28, 2025. This follows an earlier interim dividend of Rs.2/- per equity share declared on August 12, 2025.

In parallel, the board has approved the incorporation of a wholly-owned subsidiary in India. This new entity will serve as the resulting company for the demerger of Natco Pharma's crop health sciences division, a move aimed at unlocking value and enhancing long-term growth. The indicative completion period for the incorporation is December 31, 2025, with an initial capital contribution of Rs.1,00,000/-.

The company reported consolidated total revenue of INR 1,463.0 Crore for the quarter ended September 30, 2025, compared to INR 1,434.9 Crore in the same period last year. Consolidated net profit for the quarter was INR 517.9 Crore.